Clinical Trial Update: Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating non-selective beta-blockers to prevent decompensation in cirrhosis with portal hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis
• Esophageal Varices
• Hepatic Encephalopathy
• Portal Hypertension
• Portal Hypertensive Gastropathy
• Spontaneous Bacterial Peritonitis

Drugs mentioned

• CARVEDILOL (Carvedilol)
• Nadolol (Nadolol)
• Propranolol (propranolol)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Portal Hypertension Gastropathy, Esophageal Varices | Phase 4 | Status: COMPLETED